CBD Life Sciences, Inc. (CBDL)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
CBD Life Sciences Enterprise Value : -0.4736M for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | -0.4736M |
| November 03, 2026 | 0.7424M |
| November 02, 2026 | 0.7424M |
| October 30, 2026 | 0.7424M |
| October 29, 2026 | 0.7424M |
| October 28, 2026 | 0.7424M |
| October 27, 2026 | 0.7424M |
| October 26, 2026 | 0.4369M |
| October 23, 2026 | 0.7424M |
| October 22, 2026 | 0.5285M |
| October 21, 2026 | 0.7424M |
| October 20, 2026 | 0.4369M |
| October 19, 2026 | 0.7424M |
| October 16, 2026 | 0.7424M |
| October 15, 2026 | 0.1314M |
| October 14, 2026 | 0.7424M |
| October 13, 2026 | 0.7424M |
| October 12, 2026 | 0.7424M |
| October 09, 2026 | 0.7424M |
| October 08, 2026 | 0.7424M |
| October 07, 2026 | 0.498M |
| October 06, 2026 | 0.7424M |
| October 05, 2026 | 0.7424M |
| October 02, 2026 | 0.7424M |
| October 01, 2026 | 0.7424M |
| Date | Value |
|---|---|
| September 30, 2026 | 0.7424M |
| September 29, 2026 | 0.498M |
| September 28, 2026 | 0.7424M |
| September 25, 2026 | 0.1314M |
| September 24, 2026 | 0.1314M |
| September 23, 2026 | 0.7424M |
| September 22, 2026 | 0.7424M |
| September 21, 2026 | 0.7424M |
| September 18, 2026 | 0.7424M |
| September 17, 2026 | 0.7424M |
| September 16, 2026 | 0.7424M |
| September 15, 2026 | 0.7424M |
| September 14, 2026 | 0.4369M |
| September 11, 2026 | 0.7424M |
| September 10, 2026 | 0.7424M |
| September 09, 2026 | 0.7424M |
| September 08, 2026 | 0.7424M |
| September 04, 2026 | 0.7424M |
| September 03, 2026 | 0.7424M |
| September 02, 2026 | 0.4369M |
| September 01, 2026 | 0.7424M |
| August 31, 2026 | 0.7424M |
| August 28, 2026 | 0.7424M |
| August 27, 2026 | 0.7424M |
| August 26, 2026 | 0.7424M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ashland, Inc. | 4.492B |
| Achieve Life Sciences, Inc. | 544.61M |
| BioAdaptives, Inc. | 0.5522M |
| BellRing Brands, Inc. | 2.273B |
| Aspire-Lakewood Holdings, Inc. | -2.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0061M |
| Revenue (Quarterly) | 0.0132M |
| Total Expenses (Quarterly) | 0.0072M |
| Gross Profit Margin (Quarterly) | 95.45% |
| Profit Margin (Quarterly) | 46.21% |